The GPR171 pathway suppresses T cell activation and limits antitumor immunity.
Fujiwara Y, Torphy RJ, Sun Y, Miller EN, Ho F, Borcherding N, Wu T, Torres RM, Zhang W, Schulick RD, Zhu Y.
Fujiwara Y, et al. Among authors: schulick rd.
Nat Commun. 2021 Oct 6;12(1):5857. doi: 10.1038/s41467-021-26135-9.
Nat Commun. 2021.
PMID: 34615877
Free PMC article.